Short answer
Varex Imaging Corp (VREX) filed its Q3 2026 10-Q quarterly report on Aug 10, 2026 for the quarter ended Jul 3, 2026. Quarterly revenue was $211M (up 3.7% year over year) with net income of $16M.
Q3 2026 key financials · XBRL
- Revenue
- $211M
- +3.7% YoY · −2.5% QoQ
- Net income
- $16M
- +117.6% YoY · +293.8% QoQ
- Operating margin
- 10.8%
- Gross margin
- 36.4%
- EPS (diluted)
- $0.37
- +117.1% YoY · +294.7% QoQ
Source: XBRL data from the Varex Imaging Corp (VREX) Q3 2026 10-Q on SEC EDGAR. USD.
Varex Imaging Corp Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $210.5M, up 3.7% YoY from $203.0M, led by Industrial growth
- Gross margin 36.4% vs 33.3% YoY; excluding tariff items, approximately 30.6% vs 33.3%
- Industrial revenue $76.5M, up 25.6%; Medical revenue $134.0M, down 5.7%
- Industrial gross margin 37.1% vs 34.2%; Medical gross margin 36.0% vs 32.9%
- $17.0M IEEPA refunds received; tariffs, supply disruption, and trade uncertainty remain near-term headwinds
Risk Factors
- Teledyne merger announced August 10, 2026, creating new closing, disruption, litigation, and termination risks
- Regulatory approval risk across U.S., China, and other jurisdictions, with potential conditions delaying or preventing closing
- Tariff exposure from U.S.–China measures and MOFCOM investigations affecting CT-tube exports, costs, and margins
- Customer concentration: top ten customers represented 53% of quarterly revenue, with one customer at 15%
- International exposure: non-U.S. customers generated 71% of quarterly revenue, increasing currency and geopolitical sensitivity
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Varex Imaging Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.